Critical Care Aspects of Malaria

Journal of Intensive Care Medicine

Volumn 25, Issue 2, 2010, Pages 93-103

  Sarkar, Pralay K ^a,b   Ahluwalia, Gautam ^c   Vijayan, Vannan K ^d   Talwar, Arunabh ^a,b  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^b LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^c DAYANAND MEDICAL COLLEGE AND HOSPITAL   (India)

^d UNIVERSITY OF DELHI   (India)

Author keywords

ARDS; Cerebral; Malaria; Renal failure

Indexed keywords

ACETYLCYSTEINE; ARTEMETHER; ARTEMISININ DERIVATIVE; ARTESUNATE; BENZODIAZEPINE DERIVATIVE; CLINDAMYCIN; DEFERIPRONE; DEFEROXAMINE; DOXYCYCLINE; DROTRECOGIN; FANSIDAR; MANNITOL; PENTOXIFYLLINE; PHENOBARBITAL; PHENYTOIN; QUINIDINE GLUCONATE; QUININE; STEROID; TETRACYCLINE;

ACUTE KIDNEY FAILURE; ACUTE LUNG INJURY; ACUTE RESPIRATORY FAILURE; ADULT RESPIRATORY DISTRESS SYNDROME; ANEMIA; BLEEDING; BLOOD SMEAR; BRAIN MALARIA; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CONTINUOUS INFUSION; DISEASE SEVERITY; DIZZINESS; DRUG EFFICACY; DRUG FATALITY; EXCHANGE BLOOD TRANSFUSION; FLUORESCENCE MICROSCOPY; GASTROINTESTINAL DISEASE; HEARING LOSS; HEART ARRHYTHMIA; HEMATOLOGIC DISEASE; HUMAN; HYPOGLYCEMIA; INTENSIVE CARE; LABORATORY DIAGNOSIS; LIVER DISEASE; LOADING DRUG DOSE; MALARIA; MALARIA FALCIPARUM; METABOLIC DISORDER; MORTALITY; MULTIPLE ORGAN FAILURE; NAUSEA; NEUROLOGIC DISEASE; PATHOGENESIS; PATHOPHYSIOLOGY; PATIENT CARE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; QT PROLONGATION; RECOMMENDED DRUG DOSE; REVIEW; SEIZURE; THROMBOCYTOPENIA; TINNITUS; VISUAL DISORDER;

ACUTE KIDNEY INJURY; ANTIMALARIALS; CRITICAL CARE; HUMANS; MALARIA, FALCIPARUM; SEVERITY OF ILLNESS INDEX;

EID: 77950224301     PISSN: 08850666     EISSN: 15251489     Source Type: Journal    
DOI: 10.1177/0885066609356052     Document Type: Review

References (91)

1. Breman JG The ears of the hippopotamus: manifestations, determinants, estimates of the malaria burden. Am J Trop Med Hyg. 2001 ; 64 (1-2 suppl). 1-11.
2. Newman RD, Parise ME, Barber AM, Steketee RW Malaria-related deaths among U.S. travelers, 1963-2001. Ann Intern Med. 2004 ; 141 (7). 547-555.
3. Mali S., Steele S., Slutsker L., Arguin PM, and Centers for Disease Control and Prevention (CDC). Malaria surveillance-United States, 2006. MMWR Surveill Summ. 2008 ; 57 (5). 24-39.
4. Kumar S., Melzer M., Dodds P., Watson J., Ord R. P. vivax malaria complicated by shock and ARDS. Scand J Infect Dis. 2007 ; 39 (3). 255-256.
5. Thapa R., Patra V., Kundu R. Plasmodium vivax cerebral malaria. Indian Pediatr. 2007 ; 44 (6). 433-434.
6. Shubhakaran. Acute renal failure in Plasmodium vivax malaria. J Assoc Physicians India. 2005 ; 53: 655 ; author reply 655-656.
7. Silamut K., Phu NH, Whitty C., et al. A quantitative analysis of the microvascular sequestration of malaria parasites in the human brain. Am J Pathol. 1999 ; 155 (2). 395-410.
8. Pouvelle B., Buffet PA, Lepolard C., Scherf A., Gysin J. Cytoadhesion of Plasmodium falciparum ring-stage-infected erythrocytes. Nat Med. 2000 ; 6 (11). 1264-1268.
9. Baruch DI, Gormely JA, Ma C., Howard RJ, Pasloske BL Plasmodium falciparum erythrocyte membrane protein 1 is a parasitized erythrocyte receptor for adherence to CD36, thrombospondin, intercellular adhesion molecule 1. Proc Natl Acad Sci U S A. 1996 ; 93 (8). 3497-3502.
10. Reeder JC, Cowman AF, Davern KM, et al. The adhesion of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate A is mediated by P. Falciparum erythrocyte membrane protein 1. Proc Natl Acad Sci U S A. 1999 ; 96 (9). 5198-5202.
11. Rowe JA, Moulds JM, Newbold CI, Miller LH P. falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1. Nature. 1997 ; 388 (6639). 292-295.
12. Cockburn IA, Mackinnon MJ, O'Donnell A., et al. A human complement receptor 1 polymorphism that reduces Plasmodium falciparum rosetting confers protection against severe malaria. Proc Natl Acad Sci U S A. 2004 ; 101 (1). 272-277.
13. Glenister FK, Coppel RL, Cowman AF, Mohandas N., Cooke BM Contribution of parasite proteins to altered mechanical properties of malaria-infected red blood cells. Blood. 2002 ; 99 (3). 1060-1063.
14. van der Heyde HC, Nolan J., Combes V., Combes V., Gramaglia I., Grau GE A unified hypothesis for the genesis of cerebral malaria: sequestration, inflammation and hemostasis leading to microcirculatory dysfunction. Trends Parasitol. 2006 ; 22 (11). 503-508.
15. Kwiatkowski D., Hill AV, Sambou I., et al. TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet. 1990 ; 336 (8725). 1201-1204.
16. Hunt NH, Golenser J., Chan-Ling T., et al. Immunopathogenesis of cerebral malaria. Int J Parasitol. 2006 ; 36 (5). 569-582.
17. Medana IM, Hunt NH, Chaudhri G. Tumor necrosis factor-alpha expression in the brain during fatal murine cerebral malaria: evidence for production by microglia and astrocytes. Am J Pathol. 1997 ; 150 (4). 1473-1486.
18. Mibei EK, Orago AS, Stoute JA Immune complex levels in children with severe Plasmodium falciparum malaria. Am J Trop Med Hyg. 2005 ; 72 (5). 593-599.
19. Wassmer SC, Combes V., Grau GE Pathophysiology of cerebral malaria: role of host cells in the modulation of cytoadhesion. Ann N Y Acad Sci. 2003 ; 992: 30-38.
20. Weyrich AS, Zimmerman GA Platelets: signaling cells in the immune continuum. Trends Immunol. 2004 ; 25 (9). 489-495.
21. Clemens R., Pramoolsinsap C., Lorenz R., Pukrittayakamee S., Bock HL, White NJ Activation of the coagulation cascade in severe falciparum malaria through the intrinsic pathway. Br J Haematol. 1994 ; 87 (1). 100-105.
22. Gillrie MR, Krishnegowda G., Lee K., et al. Src-family kinase dependent disruption of endothelial barrier function by Plasmodium falciparum merozoite proteins. Blood. 2007 ; 110 (9). 3426-3435.
23. Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. Trans R Soc Trop Med Hyg. 2000 ; 94 (suppl 1). S1 - S90.
24. Idro R., Ndiritu M., Ogutu B., et al. Burden, features, and outcome of neurological involvement in acute falciparum malaria in Kenyan children. JAMA. 2007 ; 297 (20). 2232-2240.
25. Crawley J., Smith S., Kirkham F., Muthinji P., Waruiru C., Marsh K. Seizures and status epilepticus in childhood cerebral malaria. Qjm. 1996 ; 89 (8). 591-597.
26. Molyneux ME, Taylor TE, Wirima JJ, Borgstein A. Clinical features and prognostic indicators in paediatric cerebral malaria: a study of 131 comatose Malawian children. Q J Med. 1989 ; 71 (265). 441-459.
27. James MF Pulmonary damage associated with falciparum malaria: a report of ten cases. Ann Trop Med Parasitol. 1985 ; 79 (2). 123-138.
28. Rajput R., Singh H., Singh S., Meena, Tiwari UC. Pulmonary manifestations in malaria. J Indian Med Assoc. 2000 ; 98 (10). 612-614.
29. Anstey NM, Jacups SP, Cain T., et al. Pulmonary manifestations of uncomplicated falciparum and vivax malaria: cough, small airways obstruction, impaired gas transfer, increased pulmonary phagocytic activity. J Infect Dis. 2002 ; 185 (9). 1326-1334.
30. Hovette P., Camara P., Burgel PR, Mbaye PS, Sane M., Klotz F. Pulmonary manifestations associated with malaria [in French]. Rev Pneumol Clin. 1998 ; 54 (6). 340-345.
31. Punyagupta S., Srichaikul T., Nitiyanant P., Petchclai B. Acute pulmonary insufficiency in falciparum malaria: summary of 12 cases with evidence of disseminated intravascular coagulation. Am J Trop Med Hyg. 1974 ; 23 (4). 551-559.
32. Gachot B., Wolff M., Nissack G., Veber B., Vachon F. Acute lung injury complicating imported Plasmodium falciparum malaria. Chest. 1995 ; 108 (3). 746-749.
33. Agarwal R., Nath A., Gupta D. Noninvasive ventilation in Plasmodium vivax related ALI/ARDS. Intern Med. 2007 ; 46 (24). 2007-2011.
34. Lee EY, Maguire JH Acute pulmonary edema complicating ovale malaria. Clin Infect Dis. 1999 ; 29 (3). 697-698.
35. Charoenpan P., Indraprasit S., Kiatboonsri S., Suvachittanont O., Tanomsup S. Pulmonary edema in severe falciparum malaria. Hemodynamic study and clinicophysiologic correlation. Chest. 1990 ; 97 (5). 1190-1197.
36. Ehrhardt S., Wichmann D., Hemmer CJ, Burchard GD, Brattig NW Circulating concentrations of cardiac proteins in complicated and uncomplicated Plasmodium falciparum malaria. Trop Med Int Health. 2004 ; 9 (10). 1099-1103.
37. Trang TT, Phu NH, Vinh H., et al. Acute renal failure in patients with severe falciparum malaria. Clin Infect Dis. 1992 ; 15 (5). 874-880.
38. Kaballo BG, Khogali MS, Khalifa EH, Khaiii EA, Ei-Hassan AM, Abu-Aisha H. Patterns of ĝ€ĝ€severe acute renal failure'' in a referral center in Sudan: excluding intensive care and major surgery patients. Saudi J Kidney Dis Transpl. 2007 ; 18 (2). 220-225.
39. Barsoum RS Malarial acute renal failure. J Am Soc Nephrol. 2000 ; 11 (11). 2147-2154.
40. Maheshwari A., Singh AK, Sinha DK, Tripathi K., Prakash J. Spectrum of renal disease in malaria. J Indian Med Assoc. 2004 ; 102 (3). 143 ; 146, 148 passim..
41. Sitprija V. Nephropathy in falciparum malaria. Kidney Int. 1988 ; 34 (6). 867-877.
42. Krishna S., Waller DW, ter Kuile F., et al. Lactic acidosis and hypoglycaemia in children with severe malaria: pathophysiological and prognostic significance. Trans R Soc Trop Med Hyg. 1994 ; 88 (1). 67-73.
43. Day NP, Phu NH, Mai NT, et al. The pathophysiologic and prognostic significance of acidosis in severe adult malaria. Crit Care Med. 2000 ; 28 (6). 1833-1840.
44. Phillips RE, Pasvol G. Anaemia of Plasmodium falciparum malaria. Baillieres Clin Haematol. 1992 ; 5 (2). 315-330.
45. Akingbola TS, Shokunbi WA, Olumese PE Coagulation profile in Nigerian children with cerebral malaria. Niger Postgrad Med J. 2006 ; 13 (3). 195-199.
46. Murthy GL, Sahay RK, Srinivasan VR, Upadhaya AC, Shantaram V., Gayatri K. Clinical profile of falciparum malaria in a tertiary care hospital. J Indian Med Assoc. 2000 ; 98 (4). 160-162, 169.
47. Kato Y., Ohnishi K., Sawada Y., Suenaga M. Purpura fulminans: an unusual manifestation of severe falciparum malaria. Trans R Soc Trop Med Hyg. 2007 ; 101 (10). 1045-1047.
48. Ohnishi K., Mitsui K., Komiya N., Iwasaki N., Akashi A., Hamabe Y. CLINICAL case report: falciparum malaria with hemophagocytic syndrome. Am J Trop Med Hyg. 2007 ; 76 (6). 1016-1018.
49. Das SN, Mohapatra B., Mohanty R., Dash PC, Kar K., Dash PK Malarial hepatitis as a component of multiorgan failure-a bad prognostic sign. J Indian Med Assoc. 2007 ; 105 (5). 247-250.
50. Anand AC, Puri P. Jaundice in malaria. J Gastroenterol Hepatol. 2005 ; 20 (9). 1322-1332.
51. Bruneel F., Gachot B., Timsit JF, et al. Shock complicating severe falciparum malaria in European adults. Intensive Care Med. 1997 ; 23 (6). 698-701.
52. Molyneux ME, Looareesuwan S., Menzies IS, et al. Reduced hepatic blood flow and intestinal malabsorption in severe falciparum malaria. Am J Trop Med Hyg. 1989 ; 40 (5). 470-476.
53. Moody A. Rapid diagnostic tests for malaria parasites. Clin Microbiol Rev. 2002 ; 15 (1). 66-78.
54. Boisier P., Jambou R., Raharimalala L., Roux J. Relationship between parasite density and fever risk in a community exposed to a low level of malaria transmission in Madagascar highlands. Am J Trop Med Hyg. 2002 ; 67 (2). 137-140.
55. Rogier C., Commenges D., Trape JF Evidence for an age-dependent pyrogenic threshold of Plasmodium falciparum parasitemia in highly endemic populations. Am J Trop Med Hyg. 1996 ; 54 (6). 613-619.
56. Murray CK, Gasser RA Jr, Magill AJ, Miller RS Update on rapid diagnostic testing for malaria. Clin Microbiol Rev. 2008 ; 21 (1). 97-110.
57. Kain KC, Harrington MA, Tennyson S., Keystone JS Imported malaria: prospective analysis of problems in diagnosis and management. Clin Infect Dis. 1998 ; 27 (1). 142-149.
58. Bell D., Peeling RW Evaluation of rapid diagnostic tests: malaria. Nat Rev Microbiol. 2006 ; 4 (9 suppl). S34 - S38.
59. Baker J., McCarthy J., Gatton M., et al. Genetic diversity of Plasmodium falciparum histidine-rich protein 2 (PfHRP2) and its effect on the performance of PfHRP2-based rapid diagnostic tests. J Infect Dis. 2005 ; 192 (5). 870-877.
60. Lee N., Baker J., Andrews KT, et al. Effect of sequence variation in Plasmodium falciparum histidine- rich protein 2 on binding of specific monoclonal antibodies: Implications for rapid diagnostic tests for malaria. J Clin Microbiol. 2006 ; 44 (8). 2773-2778.
61. Guthmann JP, Ruiz A., Priotto G., Kiguli J., Bonte L., Legros D. Validity, reliability and ease of use in the field of five rapid tests for the diagnosis of Plasmodium falciparum malaria in Uganda. Trans R Soc Trop Med Hyg. 2002 ; 96 (3). 254-257.
62. van den Broek I., Hill O., Gordillo F., et al. Evaluation of three rapid tests for diagnosis of P. Falciparum and P. Vivax malaria in Colombia. Am J Trop Med Hyg. 2006 ; 75 (6). 1209-1215.
63. Gasser RA, Magill AJ, Ruebush T., et al. Malaria diagnosis: performance of NOW ICT Malaria in a large scale field trial. (abstr. 2338). 54th Annual Meeting (Washington DC) Am. Soc. Trop. Med. Hyg.; 2005.
64. Ratsimbasoa A., Fanazava L., Radrianjafy R., Ramilijaona J., Rafanomezantsoa H., Ménard D. Evaluation of two new immunochromatographic assays for diagnosis of malaria. Am J Trop Med Hyg. 2008 ; 79 (5). 670-672.
65. Postigo M., Mendoza-Leon A., Perez HA Malaria diagnosis by the polymerase chain reaction: a field study in south-eastern Venezuela. Trans R Soc Trop Med Hyg. 1998 ; 92 (5). 509-511.
66. Wang X., Zhu S., Liu Q., et al. Field evaluation of the QBC technique for rapid diagnosis of vivax malaria. Bull World Health Organ. 1996 ; 74 (6). 599-603.
67. Pukrittayakamee S., Supanaranond W., Looareesuwan S., Vanijanonta S., White NJ Quinine in severe falciparum malaria: evidence of declining efficacy in Thailand. Trans R Soc Trop Med Hyg. 1994 ; 88 (3). 324-327.
68. Zongo I., Dorsey G., Rouamba N., et al. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemetherlumefantrine, dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso. Clin Infect Dis. 2007 ; 45 (11). 1453-1461.
69. Karunajeewa HA, Mueller I., Senn M., et al. A trial of combination antimalarial therapies in children from Papua New Guinea. N Engl J Med. 2008 ; 359 (24). 2545-2557.
70. Noedl H., Se Y., Schaecher K., et al. Evidence of Artemisinin-Resistant Malaria in Western Cambodia. N Engl J Med. 2008 ; 359 (24). 2619-2620.
71. Artemether-Quinine Meta-analysis Study Group. A meta-analysis using individual patient data of trials comparing artemether with quinine in the treatment of severe falciparum malaria. Trans R Soc Trop Med Hyg. 2001 ; 95 (6). 637-650.
72. Dondorp A., Nosten F., Stepniewska K., et al. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet. 2005 ; 366 (9487). 717-725.
73. Guidelines for the Treatment of Malaria. Geneva: World Health Organization, 2006. http://www.who.int/malaria/docs/Treatment-Guidelines2006. pdf. Accessed March 28, 2008.
74. Rosenthal PJ Artesunate for the treatment of severe falciparum malaria. N Engl J Med. 2008 ; 358 (17). 1829-1836.
75. Lalloo DG, Shingadia D., Pasvol G., et al. UK malaria treatment guidelines. J Infect. 2007 ; 54 (2). 111-121.
76. Moore DA, Jennings RM, Doherty TF, et al. Assessing the severity of malaria. BMJ. 2003 ; 326 (7393). 808-809.
77. Day NP, Hien TT, Schollaardt T., et al. The prognostic and pathophysiologic role of pro- and antiinflammatory cytokines in severe malaria. J Infect Dis. 1999 ; 80 (4). 1288-1297.
78. White NJ The management of severe falciparum malaria. Am J Respir Crit Care Med. 2003 ; 167 (5). 673-674.
79. Miller KD, Greenberg AE, Campbell CC Treatment of severe malaria in the United States with a continuous infusion of quinidine gluconate and exchange transfusion. N Engl J Med. 1989 ; 321 (2). 65-70.
80. Treatment of severe malaria by exchange transfusion. N Engl J Med. 1990 ; 322 (1). 58-59.
81. Riddle MS, Jackson JL, Sanders JW, et al. Exchange transfusion as an adjunct therapy in severe Plasmodium falciparum malaria: a meta-analysis. Clin Infect Dis. 2002 ; 34 (9). 1192-1198.
82. Kendrick BJ, Gray AG, Pickworth A., Watters MP Drotrecogin alfa (activated) in severe falciparum malaria. Anaesthesia. 2006 ; 61 (9). 899-902.
83. Rankin LG, Austin DL The use of activated protein C in severe Plasmodium falciparum malaria. Anaesth Intensive Care. 2007 ; 35 (3). 428-432.
84. Mohanty S., Patel DK, Pati SS, Mishra SK Adjuvant therapy in cerebral malaria. Indian J Med Res. 2006 ; 124 (3). 245-260.
85. Mishra SK, Mohanty S., Satpathy SK, Mohapatra DN Cerebral malaria in adults-a description of 526 cases admitted to Ispat General Hospital in Rourkela. Ann Trop Med Parasitol. 2007 ; 101 (3). 187-193.
86. Bruneel F., Hocqueloux L., Alberti C., et al. The clinical spectrum of severe imported falciparum malaria in the intensive care unit: report of 188 cases in adults. Am J Respir Crit Care Med. 2003 ; 167 (5). 684-689.
87. Tran TH, Day NP, Nguyen HP, et al. A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria. N Engl J Med. 1996 ; 335 (2). 76-83.
88. Mohanty S., Mishra SK, Pati SS, Pattnaik J., Das BS Complications and mortality patterns due to Plasmodium falciparum malaria in hospitalized adults and children, Rourkela, Orissa, India. Trans R Soc Trop Med Hyg. 2003 ; 97 (1). 69-70.
89. Mishra SK, Panigrahi P., Mishra R., Mohanty S. Prediction of outcome in adults with severe falciparum malaria: a new scoring system. Malar J. 2007 ; 6: 24.
90. Marsh K., Forster D., Waruiru C., et al. Indicators of life-threatening malaria in African children. N Engl J Med. 1995 ; 332 (21). 1399-1404.
91. Losert H., Schmid K., Wilfing A., et al. Experiences with severe P. Falciparum malaria in the intensive care unit. Intensive Care Med. 2000 ; 26 (2). 195-201.